Håvar Knutsen

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia

Kimmo Porkka, Perttu Koskenvesa, Tuija Lundán et al. · Blood · 2008 · 443 citations · Full text

Medicine, Hematology, Oncology +13

Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis

Helna Pettersson, Håvar Knutsen, Erik Holmberg et al. · European Journal Of Haematology · 2014 · 38 citations

Medicine, Oncology, Pathology +14

Inflammatory functional iron deficiency common in myelofibrosis, contributes to anaemia and impairs quality of life. From the Nordic MPN study Group

Gunnar Birgegård, Jan Samuelsson, Erik Ahlstrand et al. · European Journal Of Haematology · 2018 · 37 citations

Medicine, Hematology, Immunology +16

Genetic variation in <i><scp>IL</scp>28B</i> (<i><scp>IFNL</scp>3</i>) and response to interferon‐alpha treatment in myeloproliferative neoplasms

Marie Lindgren, Jan Samuelsson, Lars Nilsson et al. · European Journal Of Haematology · 2018 · 23 citations

Life Sciences, Genetics, Hematology +17

Thyrotropin‐releasing Hormone Antagonism of Ethanol Inebriation

Håvar Knutsen, L. Ø. Dolva, Sverre Skrede et al. · Alcoholism Clinical and Experimental Research · 1989 · 16 citations

Medicine, Pharmacology, Psychology +15